Oncogenic RAS signaling increases tumor cell surface expression of PD‐L1 and/or B7‐H3 by a mechanism that promotes an increase in mRNA stability by modulation of the AU‐rich element‐binding protein tristetraprolin (TTP).41 The gene discussed is CD274; the disease is neoplasm.